Ownership and insider activity for Autonomix Medical, Inc. (AMIX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Price
| Price | $4.12 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-03 | KLEMP WALTER V | A-Award | 13,000 | |
| 2026-09-03 | Bisson Lori | A-Award | 13,000 | |
| 2026-09-03 | Hauser Bradley | A-Award | 27,000 | |
| 2025-08-11 | Hauser Bradley | D-Return | 45,000 | $1.2M |
| 2025-08-11 | Capelli Christopher | D-Return | 3,750 | $150K |
| 2025-08-11 | KLEMP WALTER V | D-Return | 8,773 | $233K |
| 2025-08-11 | Bisson Lori | D-Return | 18,862 | $501K |
| 2025-08-11 | Bisson Lori | D-Return | 46,680 | $1.9M |
| 2025-08-11 | Smith Trent N. | D-Return | 11,405 | $303K |
| 2025-08-11 | Smith Trent N. | D-Return | 21,250 | $850K |
Balance Sheet (10y)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2.0M | $865000 | $8.6M | $9.1M | $7.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $2.1M | $865000 | $9.4M | $9.6M | $7.6M |
| Property, Plant & Equipment | 0 | 0 | $16000 | $21000 | $19000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | $2.1M | $865000 | $9.4M | $9.8M | $7.6M |
| Accounts Payable | $91622 | $173000 | $492000 | $676000 | $700000 |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $93242 | $221000 | $777000 | $1.7M | $1.7M |
| Long-term Debt | 0 | 0 | $1.0M | 0 | 0 |
| Total Liabilities | $93242 | $221000 | $1.8M | $1.7M | $1.7M |
| Retained Earnings | -$21.6M | -$23.5M | -$39.0M | -$50.4M | -$67.1M |
| Total Equity | $2.0M | $644000 | $7.6M | $8.1M | $5.9M |
| Total Debt | 0 | 0 | $1.0M | 0 | 0 |
| Net Debt | -$2.0M | -$865000 | -$7.6M | -$9.1M | -$7.0M |
| Working Capital | $2.0M | $644000 | $8.6M | $7.9M | $5.9M |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 4.85 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -17.84 |
Profitability
| Return on Equity | -267.73% |
| Return on Invested Capital | -518.15% |
| Return on Assets | -404.67% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: AIM · BBLG · DHAI · FLGC · HSCS · KALA · MOVE
Explore sector: Healthcare · Medical - Devices
More sections of AMIX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks